Long-term safety of proton pump inhibitor therapy assessed under controlled, randomised clinical trial conditions: data from the SOPRAN and LOTUS studies-Reference-Cited by-同舟云学术

Long-term safety of proton pump inhibitor therapy assessed under controlled, randomised clinical trial conditions: data from the SOPRAN and LOTUS studies

Published:2015-04-10 Issue:11 Volume:41 Page:1162-1174
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Attwood S. E.¹,Ell C.²,Galmiche J. P.³,Fiocca R.⁴,Hatlebakk J. G.⁵,Hasselgren B.⁶,Långström G.⁶,Jahreskog M.⁶,Eklund S.⁶,Lind T.⁶,Lundell L.⁷

Affiliation:

1. North Tyneside General Hospital; North Shields UK

2. Sana Klinikum Offenbach; Frankfurt Germany

3. Hôtel Dieu-CHU de Nantes; Nantes France

4. University of Genoa and IRCCS S. Martino; Genoa Italy

5. Haukeland University Hospital; Bergen Norway

6. AstraZeneca R&D; Mölndal Sweden

7. Department of Surgery; Centre for Digestive Diseases; Karolinska University Hospital; CLINTEC; Karolinska Institutet; Stockholm Sweden

Funder

Astra Zeneca supported this project

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/apt.13194/fullpdf

Reference33 articles.

1. The risks of PPI therapy;Moayyedi;Nat Rev Gastroenterol Hepatol,2012

2. Safety of long-term PPI therapy;Reimer;Best Pract Res Clin Gastroenterol,2013

3. Long-term safety concerns with proton pump inhibitors;Ali;Am J Med,2009

4. Expert position paper on the use of proton pump inhibitors in patients with cardiovascular disease and antithrombotic therapy;Agewall;Eur Heart J,2013

5. Recent safety concerns with proton pump inhibitors;Chen;J Clin Gastroenterol,2012

Cited by 123 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-Term Proton Pump Inhibitor–Acid Suppressive Treatment Can Cause Vitamin B12 Deficiency in Zollinger–Ellison Syndrome (ZES) Patients;International Journal of Molecular Sciences;2024-07-02

2. Role of prescribed medication in the development of iron deficiency anaemia in adults—a case–control study;BMJ Open Gastroenterology;2024-06

3. PPI use is not associated with bone microarchitecture and strength assessed with HR-pQCT after three-years follow-up in patients visiting the Fracture Liaison Service;Bone;2024-05

4. Effect of long-term proton pump inhibitors on phosphocalcium metabolism and bone mineral density;Future Science OA;2024-04-17

5. Impact of STAT6 Variants on the Response to Proton Pump Inhibitors and Comorbidities in Patients with Eosinophilic Esophagitis;International Journal of Molecular Sciences;2024-03-26